About this trial
Vulval cancer is a rare cancer, affecting about 70 women in Ireland each year. Survivors may face challenges related to treatment side effects, sexual functioning, body image, and relationships. The Mater Hospital is conducting a survey in which they aim to understand the long term impact vulvar cancer has on patients and how it’s treatments can impact a woman’s life. This is including physical health, emotional well-being and sexual functioning.
Patient Profile
History of vulval cancer, not undergoing active CT/RT.
Where’s this trial being run?
Mater Misericordiae University Hospital
Can I join this study / trial?
The first step we recommend is to talk to your doctor or the cancer trials team at your hospital. You can find contact details for cancer trials research units in Ireland here.
It’s also a good idea to print this page and bring it with you to your appointment. It can help guide the conversation and remind you of what to ask. You may also want to talk to your family or friends about your options, as they can offer support as you make decisions.
For more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | Vulval Cancer: A Focus on Survivorship |
|---|---|
| Number: | 25-40 |
| Full Title: | Vulval Cancer in Ireland: A Focus on Survivorship. A cross-sectional study to evaluate quality-of-life indices in survivors of vulval cancer. |
| Principal Investigator: | Prof. Donal Brennan (with Dr. Aisling McDonnell) |
|---|---|
| Type: | |
| Sponsor: | |
| Recruitment Started: |
Global: Ireland: April 2025 |
| Global Recruitment Target: | |
|---|---|
| Ireland Recruitment Target: | 100-110 |